Dose finding study of the intratumoral administration of the oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG)

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2017
This article has no abstract
Epistemonikos ID: 3e93d7b01b64ba5ef4e4f967356d30f4cb46b9f9
First added on: Feb 08, 2025